Literature DB >> 18714181

Risk factors for second primary tumours in breast cancer survivors.

Luis Sánchez1, Alberto Lana, Agustín Hidalgo, Jose María Rodríguez, María Del Olivo Del Valle, Antonio Cueto, María Victoria Folgueras, Elena Belyakova, Miguel Angel Comendador, María Luisa López.   

Abstract

Breast cancer (BC) survivors have an increased risk of developing second primary cancer (SPC). The aim of this study was to detect and compare SPC predictors linked to the host, the first BC and its treatment. Two hundred and seventeen patients with a nonbreast SPC and 465 matched controls, nested in the cohort of BC patients diagnosed in a Spanish region between 1975 and 2003, were involved in a case-control study. The Tumour Registry database provided information about the host, BC and its treatment factors. Their contribution to the risk of developing SPC was measured by means of a conditional logistic regression. After controlling for differences between cases and controls at baseline, obesity [odds ratio (OR): 7.48; 95% confidence interval (CI): 1.25-44.88], smoking (OR: 3.16; 95% CI: 1.23-8.15), high blood pressure (OR: 1.68; 95% CI: 1.04-2.71) and having first-degree relatives suffering from cancer (OR: 1.69; 95% CI: 1.05-2.72) were the best SPC predictors. The risk of SPC increases by 1% per month of survival from BC (OR: 1.01; 95% CI: 1.007-1.012), while having metastases (OR: 0.23; 95% CI: 0.14-0.37) and being premenopausal at diagnosis of the BC (OR: 0.44; 95% CI: 0.247-0.792) diminish the risk, probably decreasing survival. The treatments were the regression model's worst predictors. Controlling modifiable factors linked to lifestyle such as obesity and smoking is essential to prevent SPC in survivors of BC. Health education to remove persistent risk factors should be included in the treatment protocol of BC patients, because they are important predictors of SPC.

Entities:  

Mesh:

Year:  2008        PMID: 18714181     DOI: 10.1097/CEJ.0b013e3282f75ee5

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  12 in total

Review 1.  The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis.

Authors:  Sarah M Nielsen; Michael G White; Susan Hong; Briseis Aschebrook-Kilfoy; Edwin L Kaplan; Peter Angelos; Swati A Kulkarni; Olufunmilayo I Olopade; Raymon H Grogan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

Review 2.  Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.

Authors:  Balazs I Bodai; Phillip Tuso
Journal:  Perm J       Date:  2015

Review 3.  The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer.

Authors:  Bruce A Bunnell; Elizabeth C Martin; Margarite D Matossian; Courtney K Brock; Khoa Nguyen; Bridgette Collins-Burow; Matthew E Burow
Journal:  Cancer Metastasis Rev       Date:  2022-08-24       Impact factor: 9.237

Review 4.  Associations of adiposity and weight change with recurrence and survival in breast cancer patients: a systematic review and meta-analysis.

Authors:  Yuanjie Pang; Yuxia Wei; Christiana Kartsonaki
Journal:  Breast Cancer       Date:  2022-05-17       Impact factor: 3.307

5.  Other primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy.

Authors:  Min Yi; Janice N Cormier; Yan Xing; Sharon Hermes Giordano; Christy Chai; Funda Meric-Bernstam; Georges Vlastos; Henry M Kuerer; Nadeem Q Mirza; Thomas A Buchholz; Kelly K Hunt
Journal:  Ann Surg Oncol       Date:  2012-12-06       Impact factor: 5.344

Review 6.  Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.

Authors:  Lois B Travis; Wendy Demark Wahnefried; James M Allan; Marie E Wood; Andrea K Ng
Journal:  Nat Rev Clin Oncol       Date:  2013-03-26       Impact factor: 66.675

7.  Risk of second cancer after initial treatment of breast cancer: An Osaka Cancer Registry Database study.

Authors:  Yumi Kamigaki; Koji Kawakami
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

8.  Modified metabolic syndrome and second cancers in women: A case control study.

Authors:  Carlos-Manuel Ortiz-Mendoza; Ernesto Pérez-Chávez; Tania-Angélica De-la Fuente-Vera
Journal:  South Asian J Cancer       Date:  2016 Oct-Dec

9.  The untold story of late effects: a qualitative analysis of breast cancer survivors' emotional responses to late effects.

Authors:  Jodie Rosenberg; Phyllis N Butow; Joanne M Shaw
Journal:  Support Care Cancer       Date:  2021-07-10       Impact factor: 3.603

10.  Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.

Authors:  Inamul Haque; Arnab Ghosh; Seth Acup; Snigdha Banerjee; Kakali Dhar; Amitabha Ray; Sandipto Sarkar; Suman Kambhampati; Sushanta K Banerjee
Journal:  BMC Cancer       Date:  2018-01-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.